Biocon has opened a ₹4,500-crore QIP and fixed a floor price of ₹387.74 per share. The company said it may offer a discount ...

Biocon has completed the acquisition of the remaining equity shares of its unlisted subsidiary Biocon Biologics from Mylan ...

Biocon Limited board approves QIP at ₹387.74 per share, with issue opening on 12 January 2026 and new oncology biosimilars ...

Shares of Biocon saw a significant surge of over 7 percent on Tuesday, January 14, 2025, following an upgrade by global brokerage firm HSBC. The firm raised its rating on the stock to ‘Buy’ and set a ...

Biocon QIP Floor Price: Pharmaceuticals company Biocon Ltd, a constituent of BSE 200 index, has announced the opening of its qualified institutions placement (QIP). Biocon, through an exchange filing ...

In an exchange filing, the company said the approval covers Everolimus Tablets for Oral Suspension in 2 mg, 3 mg and 5 mg ...